Safe and effective use of ponatinib in a patient with chronic myeloid leukemia and acute venous thromboembolism on therapeutic anti-coagulation.

Authors :: Shomali W
Redmond C
Bogati S
Zimmerman C
Visconte V
Tabarroki A
Kalaycio M
Tiu RV
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2016; Vol. 57 (1), pp. 193-5. Date of Electronic Publication: 2015 Jun 18.
Publication Year :: 2016

Subjects :: Adult
Antineoplastic Agents administration & dosage
Antineoplastic Agents adverse effects
Disease Progression
Humans
Imidazoles administration & dosage
Imidazoles adverse effects
Leukemia, Myelogenous, Chronic, BCR-ABL Positive complications
Leukemia, Myelogenous, Chronic, BCR-ABL Positive diagnosis
Male
Protein Kinase Inhibitors administration & dosage
Protein Kinase Inhibitors adverse effects
Pyridazines administration & dosage
Pyridazines adverse effects
Treatment Outcome
Venous Thromboembolism diagnosis
Anticoagulants therapeutic use
Antineoplastic Agents therapeutic use
Imidazoles therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Protein Kinase Inhibitors therapeutic use
Pyridazines therapeutic use
Venous Thromboembolism drug therapy
Venous Thromboembolism etiology

Full Text Access

Tools